| Synonyms: | |
| Status: | Approved (2007) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | V03AE02 |
| UNII: | 941N5DUU5C |
Structure
| InChI Key | ZNSIZMQNQCNRBW-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C6H12ClNO |
| Molecular Weight | 149.62 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Kidney Failure, Chronic | Phase 3 | ClinicalTrials |
| Arteriosclerosis; Calcinosis; Hyperparathyroidism; Hyperparathyroidism, Secondary | Phase 4 | ClinicalTrials |
| Kidney Failure, Chronic; Renal Insufficiency | Phase 1 | ClinicalTrials |
| Insulin Resistance | Phase 2 | ClinicalTrials |
| Kidney Diseases; Renal Insufficiency, Chronic | Phase 2 | ClinicalTrials |
| Insulin Resistance | Phase 2 | ClinicalTrials |
| Hyperphosphatemia | Phase 1 | ClinicalTrials |
| Kidney Diseases; Renal Insufficiency, Chronic | Phase 3 | ClinicalTrials |
Related Entries
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 52757-95-6 |
| ChEMBL | CHEMBL1201798 |
| DrugBank | DB00658 |
| FDA SRS | 941N5DUU5C |
| PharmGKB | PA164781197 |
| PubChem | 3085017 |
| SureChEMBL | SCHEMBL726092 |
CONTENTS